
Professor Abubakar Yaro PhD, DSc
Director-General & Chief Scientific Officer (CSO)
The Director-General of AHRO holds the ultimate responsibility for the leadership and strategic direction of the organization. This includes developing AHRO’s scientific and academic strategies, as well as maintaining effective communication with AHRO’s partners. The Director-General reports directly to the AHRO Board of Trustees and plays a pivotal role in implementing the organization’s research and academic priorities. Key responsibilities of the Director-General include: Leadership and Strategy: Overseeing the establishment and coordination of research and academic programs across AHRO, ensuring alignment with the organization’s mission and priorities. Partnership Development: Strengthening and expanding relationships with AHRO’s network of partners, including governmental and non-governmental organizations, as well as funding agencies. Policy Influence: Utilizing evidence-based research to influence policies that advance global health initiatives. Resource Mobilization: Securing resources to support the organization’s activities and long-term sustainability. The Director-General’s Office comprises a dedicated team that provides scientific and administrative support, facilitates strategic engagement, drives resource mobilization efforts, and fosters external partnerships to advance AHRO’s mission. This role is central to AHRO’s efforts to promote evidence-based research, build collaborative networks, and contribute to the advancement of global health.
Professor Yaro is a Molecular Virologist and Infectious Diseases Scientist who possess Masters in MSc (infectious Diseases), MSc (Molecular Microbiology), Sc (Infection Biology-Specialising in Virology), PhD (Clinical Microbiology) and DSc (Emerging Infectious Diseases). Since 1997, he focused his entire career to the advancement and dissemination of scientific knowledge.
“My mission is to work hard to enable AHRO attain prominence as one of the most innovative health institutes across the globe.”
Publications
-
Yaro A (2009): Mechanism of Sulfadoxine-Pyrimethamine resistance and health implications in Plasmodium falciparum malaria: A mini review, ATMPH; 2:20-23.
-
Yaro A (2013): Epstein- Barr Infection: Current treatment options, ATMPH; 6:10-13
-
Yaro A (2016): Biomarkers of Ebola Viral Disease: Mini Review, International J of Human Virology & Retrovirology; 3:00081.DOI:10.5406/jhvrv.2016.03.00081.
-
Yaro A (2016): Advances in Dengue Vaccine: A Review Study, J of Human Virology & Retrovirology; 4: 00135. DOI: 10.15406/jhvrv.2016.04.00135.
-
Yaro A (2020): Recent Trends of research in Health Sciences in Indonesia, Ann Trop Med & Public Health; 23(S8): 1198.
-
Mufida DC, Agustine D, Arne O, Wahyudi , Yaro A (2020): Intranasal immunization with 54KDa hemegglutinin pili protein of Streptococcus pneumonia increases mucosal and systemic antibodies, Ann Trop Med & Public Health; 23(S8): 1244-1251.
-
Fadhila ZN, Herawati L, Suwerda B, Nuryunarah D, Yaro A (2020): Effectiveness of three dimension demonstration methods for waste selection behavior children’s of the Al-Qur’an mosque education park Jabal Nur in Pajangan, Bantul, Yogyarkate, Indonesia, Ann Trop Med & Public Health; 23 (S8): 1409-1418.
-
Dew I, Susilawati A, Suryono S, Purwanto P, Burlakovs J, Yaro A (2020): Coffee protects cardiovascular health by maintaining the structure of coronary arterial wall intimal collagen, Coffee Science; 2020: e151637.
-
Yaro A, Kebede S (2020): Advances in Drug and Vaccine Development for SARS-CoV-2: A review of RCT data, ATMPH Special Issue; 23 (10): 23-1049. http://doi.org/10.36295/ASRO.2020.231049
-
Al-Terehi MN, Alkaim AY, Yaro A (2020): An in silico approach to design potential siRNA molecules of SARS-CoV-2 Virus structural genes, a preliminary opinion for COVID-19 inhibition, ATMPH Special Issue; 23 (11): 23-111 http://doi.org/10.36295/ASRO.2020.23111
-
Purwanto P, Sagita YA, Lestari PE, Jani Y, Yaro A (2020): Inhibition of Candida albicans growth by steeping freeze-dried robusta ground coffee, Coffee Science; DOI: http://doi.org/10.25186/cs.v15i.1638 .
-
Yaro A, Phiri N, Nda UA (2020): Convalescent Plasma Therapy for Pandemics, COVID-19 as example: A Mini Review, ATMPH Special Issues; http://doi.org/10.36295/ASRO.2020.231341
-
Susanto H, Setyobudi RH, Sugiyanto D, Nur SM, Yandri E, Harianto H, Jani Y, Wahono JK, Adinuarani PG, Yanuar N, Yaro A (2020): Development of the biogas-energized livestock feed making machine for breeders, E3S Web of Conference; 188, 00010. DOI: https://doi.org/10.1051/e3sconf/202018800010
-
Yusuf H & Yaro A (2022): Human Malaria Infection in Nigeria: A Critical review of prevention and control techniques, AHRO Review of Nursing & Midwifery; DOI: https://doi.org/10.36295/ARNM/2022/8976
-
Yaro A, Martinoc S, Johnson C (2023): Efficacy of combined antiretroviral therapy (cART) in Hepatitis B and –C associated hepatocellular carcinoma (HCC): A narrative review, J Retroviral and Virol; 10: 73-78; DOI: https://dx.doi.org/10.15406/jhvrv.2023.10.002371
-
Yaro A, Puca E, Johnson C (2023): Strategies for improving adherence in patients with HIV/AIDS, Journal of Biomedical Research & Environmental Sciences; 4: 1675-1683; DOI: https://dx.doi.org/10.37871/jbres1851
-
Yaro A, Johnson C, Ohanyido F (2024): Paramyxoviruses: The Lurking Pandemic Pathogen; EC Microbiology; 20.2: 01-13.
-
Yaro A, Johnson C, Puca E, Ohanyido F, Bangura J (2024): Biomarkers of HIV Vaccine efficacy and safety: Review of Randomized Clinical Trials, In press.
-
Yaro A, Johnson C, Rattan A (2024): Microbicides as tools for preventing Sexual Transmitted Diseases: A narrative review of current RCT data, In press
-
Yaro A, Bangura J, Johnson C, Ohanyido F (2024): Long COVID-19 Clinical Pathophysiology & Presentations: A review of the literature based on current data, In press
-
Yaro A (2024):Therapeutic use of Silvestrol as novel antiviral agent: Review of RCTs, In press
-
Yaro A, Ohanyido F, Johnson C (2024): Repurposing approach for Paramyxoviruses: A Review, American Journal of Translational Medicine; in press
-
Yaro A, Johnson C, Mahnaz A, Pranab B (2024): Merkel Cell Polyomavirus: Molecular Biology and Carcinogenesis, In preparation
-
Yaro A, Johnson C, Rattan A (2024): In silico screening of antiviral agents for Henipaviruses: A repurposing Approach, in preparation
-
Yaro A (2024): Biomarkers in response to COVID-19 Vaccine: Synthesis of Randomized Controlled Trials, in preparation
-
Yaro A (2024): Association of Viruses and Alzheimer’s Disease: Narrative Review, In Press
-
Yaro A (2024): HHV-6 integration and its consequences: Current Advances, in press
-
Yaro A (2024): Role of multi-omics in Anti-tuberculosis drug discovery, Sanamed Journal of Medical Research, in Press
-
Yaro A, Siddiqui A, Johnson C (2024): Global Impact of Dengue Vaccine- A Scoping Review, Therapeutic Advances in Vaccines and Immunotherapy; in preparation
-
Yaro A (2024): Sapovirus: Epidemiology, Pathogenesis, Prevention, and Treatment (In concept)
-
Yaro A, Bhattacharya P (2024): Impact of COVID-19 pandemic on global microfinance system: Narrative Review (In concept)
-
Yaro A, Johnson C, Bangura J (2024): Recent advances in preventive strategies for Norovirus infection: Review (in concept)
-
Yaro A, Ashok R, Johnson C (2024): Immunotherapeutic approaches for HTLV-1 associated adult T-cell leukemia ( in concept)
-
Nyirahabimana C, Okova R, Mureithi C, Muragijimana EF, Yaro A (2024): Adaptation of stress management model for nursing students studying in selected schools of nursing in Rwanda, World J of Multidisciplinary Research & Development; 10:52-56
Books
-
Yaro A (2016): Journey through the world of Malaria (Nova Scientific Publishers Inc. USA)
-
Yaro A (2017): Ebola Virus, natural killing machine: A critical review (Author House Publishing, UK).
-
Yaro A (2018): Zika Virus: Virology & Control (Kindle Publishing, USA)
-
Yaro A (2019): Middle East Respiratory Syndrome Virus Coronavirus: Recent Advances (Kindle Publishing, USA)
-
Yaro A (2019): Resistance Pathogens (Kindle Publishing, USA)
-
Yaro A (2022): Oncoviruses: Cellular and Molecular Virology (Author House Publishing, USA)
-
Yaro A , Johnson C (2024): Scientific Theories of HIV Infection, Author House USA
-
Yaro A, Martinov S (2024): Human T-cell Lymphotropic virus (HTLV) infection: Molecular biology and Oncogenesis, Author House USA
-
Yaro A (2024): Islam in Modern world, Author House, USA
-
Yaro A (2025): The Art of Research, Author House, USA
Books chapters
-
Yaro A, Phiri A (2024): Molecular biology and pathogenesis of Coronavirus infection in Coronavirus in Coronavirus: Current research and future perspective, edited by Abubakar Yaro & Catherine Johnson, Author House, USA
-
Yaro A (2024): Antiviral and monoclonal antibody therapies in Coronavirus: Current Concept and Practices in Current research and future perspective, edited by Abubakar Yaro & Catherine Johnson, Author House, USA
-
Yaro A, Johnson C (2024): Coronavirus vaccine development: Prospect and challenges in Coronavirus: Current research and future perspective, edited by Abubakar Yaro & Catherine Johnson, Author House, USA
-
Yaro A (2024): Animal model in Coronavirus Recent advances in Coronavirus: Current research and future perspective, edited by Abubakar Yaro & Catherine Johnson, Author House, USA
-
Yaro A, Rattan A, Johnson C , Ohanyido F (2024): Drug Resistance in Four Important Human Viruses: An Updated Review, In Microbes of Medical Important, IIP Series pages 258-267
-
Yaro A, Johnson C, Pranab K (2024): EBV- associated Cancers biomarkers for diagnosis, prognosis and therapy; in Microbes of Medical important, IIP Series; pages 239-257
-
Yaro A, Johnson C, Jean B ( 2025):Emerging Pathogens and Novel Diagnostic Challenges, IIP Series in press
-
Yaro A, Siddique A, Kaniz F, Annmary M (2025): Genomics and Proteomics in Pathogen typing, IIP Series in press